David A. Siegel Medtronic PLC Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Medtronic PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 40,400 shares of MDT stock, worth $3.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,400

Previous 271,732 85.13%

Holding current value

$3.18 Million

Previous $22.4 Million 84.28%

% of portfolio

0.01%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$82.84 - $88.09 $19.2 Million - $20.4 Million	-231,332 Reduced 85.13%	40,400 $3.52 Million
Q4 2023 Feb 14, 2024	SELL	$69.43 - $83.43 $165 Million - $198 Million	-2,371,588 Reduced 89.72%	271,732 $22.4 Million
Q3 2023 Nov 14, 2023	SELL	$78.22 - $90.4 $32.6 Million - $37.6 Million	-416,300 Reduced 13.61%	2,643,320 $207 Million
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $110 Million - $127 Million	-1,385,300 Reduced 31.17%	3,059,620 $270 Million
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $69.9 Million - $79.8 Million	-911,400 Reduced 17.02%	4,444,920 $358 Million

Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $57.5 Million - $66.2 Million	754,400 Added 16.39%	5,356,320 $416 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $116 Million - $137 Million	1,439,900 Added 45.54%	4,601,920 $372 Million
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $13 Million - $16.8 Million	148,200 Added 4.92%	3,162,020 $284 Million
Q1 2022 May 16, 2022	SELL	$100.58 - $112.38 $116 Million - $130 Million	-1,157,800 Reduced 27.75%	3,013,820 $334 Million
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $119 Million - $152 Million	1,192,100 Added 40.01%	4,171,620 $432 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $37.6 Million - $41.4 Million	-306,300 Reduced 9.32%	2,979,520 $373 Million
Q2 2021 Aug 16, 2021	BUY	$118.19 - $131.5 $200 Million - $223 Million	1,694,400 Added 106.47%	3,285,820 $408 Million
Q1 2021 May 17, 2021	BUY	$111.18 - $119.74 $106 Million - $114 Million	954,500 Added 149.86%	1,591,420 $188 Million
Q4 2020 Feb 16, 2021	SELL	$100.57 - $117.14 $128 Million - $149 Million	-1,267,900 Reduced 66.56%	636,920 $74.6 Million
Q3 2020 Nov 16, 2020	BUY	$90.13 - $108.78 $29.7 Million - $35.9 Million	329,900 Added 20.95%	1,904,820 $198 Million
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $106 Million - $130 Million	1,255,988 Added 393.81%	1,574,920 $144 Million
Q1 2020 May 15, 2020	BUY	$72.92 - $121.3 $5.6 Million - $9.31 Million	76,735 Added 31.68%	318,932 $28.8 Million
Q4 2019 Feb 14, 2020	BUY	$104.49 - $114.54 $5.78 Million - $6.34 Million	55,321 Added 29.6%	242,197 $27.5 Million
Q3 2019 Nov 14, 2019	BUY	$98.02 - $111.18 $17.8 Million - $20.2 Million	181,440 Added 3337.75%	186,876 $20.3 Million
Q2 2019 Aug 14, 2019	SELL	$84.15 - $99.38 $9.74 Million - $11.5 Million	-115,766 Reduced 95.51%	5,436 $529,000
Q1 2019 May 15, 2019	SELL	$82.45 - $93.79 $27.8 Million - $31.6 Million	-336,700 Reduced 73.53%	121,202 $11 Million
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $35 Million - $40.6 Million	408,066 Added 818.82%	457,902 $41.7 Million
Q3 2018 Nov 14, 2018	BUY	$85.91 - $99.17 $2.74 Million - $3.16 Million	31,900 Added 177.85%	49,836 $4.9 Million
Q2 2018 Aug 14, 2018	SELL	$77.48 - $87.83 $25.2 Million - $28.5 Million	-324,600 Reduced 94.76%	17,936 $1.54 Million
Q1 2018 May 15, 2018	SELL	$76.55 - $87.26 $54.5 Million - $62.2 Million	-712,566 Reduced 67.54%	342,536 $27.5 Million
Q4 2017 Feb 14, 2018	SELL	$76.93 - $83.5 $10.4 Million - $11.3 Million	-135,176 Reduced 11.36%	1,055,102 $85.2 Million
Q3 2017 Nov 14, 2017	BUY	$77.71 - $84.6 $92.5 Million - $101 Million	1,190,278	1,190,278 $92.6 Million

Others Institutions Holding MDT

# of Institutions

2,235

Shares Held

1.05B

Call Options Held

6.1M

Put Options Held

7.84M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $105B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account